SI2105135T1 - Farmacevtski sestavki za zdravljenje raka - Google Patents
Farmacevtski sestavki za zdravljenje rakaInfo
- Publication number
- SI2105135T1 SI2105135T1 SI200332400T SI200332400T SI2105135T1 SI 2105135 T1 SI2105135 T1 SI 2105135T1 SI 200332400 T SI200332400 T SI 200332400T SI 200332400 T SI200332400 T SI 200332400T SI 2105135 T1 SI2105135 T1 SI 2105135T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pharmaceutical compositions
- treating cancer
- cancer
- treating
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38084202P | 2002-05-17 | 2002-05-17 | |
US42460002P | 2002-11-06 | 2002-11-06 | |
EP09008756.0A EP2105135B1 (en) | 2002-05-17 | 2003-05-16 | Pharmaceutical compositions for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2105135T1 true SI2105135T1 (sl) | 2015-01-30 |
Family
ID=49449200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200332400T SI2105135T1 (sl) | 2002-05-17 | 2003-05-16 | Farmacevtski sestavki za zdravljenje raka |
Country Status (4)
Country | Link |
---|---|
CA (2) | CA2855359A1 (sl) |
DK (1) | DK2105135T3 (sl) |
NZ (1) | NZ595125A (sl) |
SI (1) | SI2105135T1 (sl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201806322QA (en) * | 2016-01-25 | 2018-08-30 | Regeneron Pharma | Maytansinoid derivatives, conjugates thereof, and methods of use |
-
2003
- 2003-05-16 SI SI200332400T patent/SI2105135T1/sl unknown
- 2003-05-16 NZ NZ595125A patent/NZ595125A/xx not_active IP Right Cessation
- 2003-05-16 CA CA2855359A patent/CA2855359A1/en not_active Abandoned
- 2003-05-16 CA CA2855306A patent/CA2855306A1/en not_active Abandoned
- 2003-05-16 DK DK09008756.0T patent/DK2105135T3/da active
Also Published As
Publication number | Publication date |
---|---|
CA2855306A1 (en) | 2003-11-27 |
CA2855359A1 (en) | 2003-11-27 |
DK2105135T3 (da) | 2014-11-03 |
NZ595125A (en) | 2013-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI350751B (en) | Pharmaceutical compositions for treating diabetes | |
EP1535610A4 (en) | THERAPEUTIC CANCER | |
GB2389530B (en) | Pharmaceutical compositions | |
PL375532A1 (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
AU2003291103A8 (en) | Pharmaceutical composition | |
EP1468118A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
GB2391473B (en) | Pharmaceutical compositions | |
IL164896A (en) | Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors | |
EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
HU0302441D0 (en) | Pharmaceutical compositions having antibiothic effect | |
ZA200500431B (en) | Medicinal composition for treating arteriosclerosis | |
EP1626711A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER | |
IL168059A0 (en) | Benzopyranone compounds, compositions thereof, and methods for treating orpreventing cancer | |
AU2003222449A1 (en) | Medicine for treating cancer | |
HUP0600855A2 (en) | Androgen pharmaceutical composition for treating depression | |
HUP0500199A3 (en) | Pharmaceutical composition comprising arsenite for the treatment of malignancy | |
GB0213481D0 (en) | Pharmaceutical compositions | |
AU2003270202A8 (en) | Pharmaceutical compositions useful for the treatment of cancers | |
AU2002337713A1 (en) | Pharmaceutical compositions and methods for treating cancer | |
AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
EP1587405A4 (en) | NEW COMPOSITIONS AND METHODS OF CANCER | |
SI2105135T1 (sl) | Farmacevtski sestavki za zdravljenje raka | |
HUP0200253A3 (en) | Pharmaceutical compositions for combination therapy | |
GB0223325D0 (en) | Treating cancer | |
EP1712619A4 (en) | SUBSTANCE FOR THE PREVENTION AND TREATMENT OF CANCER |